Daniel Leggate
CellCentric (United Kingdom)(GB)
Research Areas
PI3K/AKT/mTOR signaling in cancer, Cancer-related Molecular Pathways, Ubiquitin and proteasome pathways, Chronic Lymphocytic Leukemia Research, Cytokine Signaling Pathways and Interactions
Most-Cited Works
- → A selective inhibitor reveals PI3Kγ dependence of TH17 cell differentiation(2012)143 cited
- → A Selective Inhibitor Reveals Pi3Kgamma Dependence of T(H)17 Cell Differentiation.(2012)24 cited
- → Erratum: Corrigendum: A selective inhibitor reveals PI3Kγ dependence of TH17 cell differentiation(2012)4 cited